TOP STORIES — Diabetes News and Research
The Relationship Between Aerobic Exercise Capacity and Cardiac Dysfunction In T2D
Possible Link Connecting COVID-19 and New-Onset Diabetes
Adding An SGLT-2 Earlier To A Treatment Plan Yields Positive A1c Levels
MOST POPULAR ARTICLES OF THE MONTH
#1 Vitamin D Supplementation Reduces the Risk of T2DM
#2 The Low-Carbohydrate Effect
#3 Vitamin D Deficiency Linked to Painful Diabetic Neuropathy
Letter from the Editor
For the past 6 months, we have heard how patients with diabetes have an increased risk of getting COVID-19, and how the symptoms will be much worse, and diabetes patients are at increased risk for death, from COVID-19 complications. Now there are a group of medical professionals who feel that the coronavirus increases the complications of diabetes, regardless of the respiratory or cardiovascular complications. They have started the CoviDIAB Registry to explore why COVID-19 can increase complications in people with pre-existing diabetes, and cause the development of diabetes.
To learn if you should register your patients on this registry, and why you should look closer at positive patients, click here.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief
TOP STORIES -- Diabetes News and Research
In type 2 diabetes patients, treating diastolic function and myocardial perfusion reserve could improve aerobic exercise capacity and prevent heart failure.
CoviDIAB Registry will explore why COVID-19 can increase complications in people with pre-existing diabetes, and may also be driving new cases.
If dapagliflozin is the second medication prescribed to the patient after the first-line treatments of metformin or sulfonylurea, it has a greater impact.